In 1996, the Panel on Cost-Effectiveness in Health and Medicine developed standards for costeffectiveness analysis. The standards include the use of a societal perspective_ that treatments be evaluated in comparison with the best available alternative (rather than with no care at all), and that health •benefits be expressed in standardized units. Guidelines for cost accounting were also offered. Among 24,562 references on cost-effectiveness in Medline between 1995 and 2000, only a handful were relevant to behavioral medicine. Only 19 studies published between 1983 and 2000 met criteria for further evaluation. Among analyses that were reported, only 2 stu_es were found consistent with the Panel's criteria for high-quality analyses, although more recent studies were more likely to meet methodological standards. There are substantial opportunities to advance behavioral medicine by performing standardized cost-effectiveness analyses.
This approach measures both program costs and treatment outspecific outcomes. For 'example, one interesting study evaluated comes in dollar units. For example, treatment outcomes are evalthe effects of different types of insurance coverage on smoking uated in relation to changes in use of medical services or in the cessationrates in a health maintenance organization (HMO; Curry, economic productivity of patients. Treatments are cost-beneficial Grothaus, McAfee, & Pabiniak, 1998) . They found that people if the economic return exceeds treatment costs. Patients with were more likely to use the smoking cessation services if there was cancer who are aggressively treated with surgery, for example, no copayment. Even though programs with copayments may be may need fewer emergency medical services. The savings associmore effective in getting participants to quit smoking, the proated with decreased services might exceed treatment costs. Somegrams with full coverage have attracted more people and resulted times investment in a service can save money. For example, in the best rate of smoking cessation in the population. However, investment in a psychotherapy program may reduce overall use of the program's main health outcome was smoking cessation. The health services (Spiegel, 1999) . The bottom line for those paying major difficulty with older cost-effectiveness methodologies is that for health services is improved because the costs of mental health they did not measure health outcomes in a comprehensivelmanner care are less than the costs of the medical services that are averted, and in common units, which does not allow for comparisons across
Although there are many reports of cost-offsets,few have been different treatment interventions. For example, health care adminreplicated or are well documented when standardized accounting istrators often need to choose between investments in very differprinciples are used. Typically, health services produce a health " ent alternatives. Should the limited amount of money be used to benefit and resources are used to obtain desired health outcomes, support tobacco cessation programs for all enrollees or should it be However, a requirement of a good cost-benefit analysis is that all devoted to supporting organ transplantation for a few patients? For outcomes have a dollar value attached. Therefore, side effects.of a the same cost, they may achieve a large effect for a few people or drug or functional limitations from a surgery must have a dollar a small effect for a large humber of people. The treatment-specific value placed on them. This poses a variety of problems because outcomes used in cost-effectiveness studies do not permit these many people are uncomfortable placing monetary values on hacomparisons across different heal_ conditions. manlife.
Therefore,thepurposeof cost-effectiveness analysisis to evalCost-offset is a term used to describe interventions that save uate the comparative potential of expenditures on different healthmoney independently of their health benefits. Most often, this care interventions. Typically, the analysis starts with the assumpsavings is related to reduced health care utilization and health tion that some resources are available to spendon health care. The care costs. Cost-offset may be present within cost-benefit or purpose of the analysis is to identify decisions that will maximize cost-effectiveness analyses, but it often shifts the focus away the amount of total health gained for the expenditure of these from whether the intervention improves health. Therefore, cost-, resources. For example; an administrator may need to decide offset is not recommended as the primary goal of intervention between supporting a program on smoking cessation and a prodevelopment, gram to screen for prostate cancer. The question is Whether.using The requirement that health care treatments reduce costs may be the resources to support smoking cessation will produce more or unrealistic (Russell, 1986 (Russell, , 1987 . Patients are willing to pa3_ for less total health benefit than would spending the same money on a improvements in health status just as they are willing to pay for prostate cancer screening project. There is not enough money to other desirable goods and services. We do not treat cancer to save support both programs, and a decision between the alternatives money. Allowing patients to die would certaiuly be less expensive, must be made. A proper comparison between the smoking cessaTreatments are given to achieve better health outcomes. In other tion program and the prostate cancer screening program can only words, treatments should be evaluated in terms of their effective-, be made if the health benefits are stated in. a common unit of hess, not just their financial benefit. Cost-effectiveness (and costmeasurement. Otherwise, an administrator may have to decide on utility analysis) are the meth0dologies used to accomplish this using resourcesto save one life versus using the same resources to evaluation, get manypeopleto stopsmokingfor 6 months.
In recent years, cost-effectiveness analysis has gained considAnother important limitation of reporting cost-effectiveness reerable attention. Some approaches emphasize simple, treatmentsuits in dollars/treatment-specific outcome is that side effects, both positive and negative, are not expressed.in the equation. When published as a book ) comparing a behavioral treatment program for depression with an and as a series of articles published in the Journal of the American antidepressant medication, the results could be easily expressed in Medical Association ; a,common measurement such as the score on a depression scale. . In the following sections, we review some However, there may be numerous side effects that are not picked Of themajor elements of cost-effectiveness analysis as defined by up by the questionnaire. The medication may have sexual side this panel.
effects, and the behavioral program may increase muscle pain. Out of this dilemma arose the concept of measuring health-related Perspective quality of life and cost-utility approaches. Cost-utility analysis is a special case of cost-effectiveness analysis that uses the expressed
The results of cost-effectiveness analysis may depend on perpreference or utility of a health state or treatment effect as the unit spective. From the societal perspective, all health care benefits and of o_utcome. It still expresses cost per health benefit; as do all costs are considered, regardless of who experiences them or pays cost-effectiveness analyses, but expresses those health benefits in for them. The administrative perspective evaluates the .problem a comprehensive manner and in units that reflect the health prefthrough the eyes of a specific agency.. Individual perspectives erences of the population. Therefore, cost-effectiveness is a consider costs and benefits from the viewpoint of an individual broader term that encompasses cost-utility analysis, and it is used citizen or patient. There may be occasions in which results differ in that context later in this article. The main feature of cost-utility dramatically as a function of perspective. An HIVIO, for example, analysis is that it uses quality-adjusted life years (QALYs) as the may Rave money by denying a particular mental health service. So, unit of analysis. We discuss this further in the Cost-Effectiveness from an adminisirative perspective, costs may be reduced; howAnalysis in Behavioral Medicine section, ever, from a societal perspective, costs may increase because other In recent years, cost-utility approaches have gained increasing agencies may be required to pay for this service or for the conseacceptance as methods for comparing many diverse options in quences of conditions being left untreated. After much considerhealth care . The goals ation, the panel decided to take a societal perspective. They conof health care .are designed both to make people live longer cluded that fair decisions must take all parties into consideration. (decrease mortality) and to help people have a higher quality of life Decision makers must wrestle with who gains and who loses, and (decrease morbidity; Kaplan, 1997) . Cost-utility studies use outthey must consider the broad consequences of decisions. Hence, come measures that combine mortality outcomes with quality of. the societal, perspective is one that simply attempts to measure all life measurements_ The utilities are the quality of life ratings or possible impacts of an intervention, both positive and negative.
preferences for observable health states on a continuum bounded .This could be extended to include changes experienced by people by 0.0 for death to 1.0 for asymptomatic optimum function who live with or care for a patient being treated, but there are (Kaplan, 1997; Kaplan, Schmidt, & Cronan, 2000; Russell, 1999;  obvious limits to how far out the indirect impact can be measured. . A It might be argued that taking the societal perspective is unrestate rated as .70, for example, is judged to be 70.0% of the way alistic. In most circumstances, resources are controlled by adminbetween death and perfect health. A year in that. state is scored as istrators who are focused on the programs that will make their .70 QALYs. We return to the discussion of QALYs later in the institutions appear to be producing the most services at the lowest article. The exact methods used to obtain a population's health cost. When the Panel on Cost-Effectiveness in Health and Medipreferences or utilities are based on economic theory and are cine reviewed this issue, they argued that the analysis should beyond the scope of this article. The topic is explained in more consider everyone affected by the intervention and that all signifdetail in many sources including Drummond (1997) and Gold icant health outcomes and costs for all people affected by the (1996) . programmust be tabulated,regardlessof who experiencesthe costs or.outcomes. An analysis done from the perspective of an Standards for Cost-Effectiveness Analysis employer might consider only the costs that affect the employer directly. These might be the effects on Work productivity or on Contrary to the portrayal of cost-effectiveness analysis in the medical bills that the employer is responsible for. This approach is popular media, the purpose of the analysis is not to cut costs but problematic because it ignores important components of the costs, rather to identify which interventions produce the greatest amount such as the bills paid directly by the employee or the consequences of health using the resources that are available. Because of the of the health outcome for other individuals. confusion about cost-effectiveness analysis, the Office of Disease
The argument for the societal perspective uses a philosophical Prevention and Health Promotion in the Public Health service exercise known as the "veil of ignorance." The exercise asks us to developed standards for cost-effectiveness analysis. In 1993, they imagine that we are making health resource allocation decisions appointed a 13-member panel cosponsored by a variety of agencies, without any information about what will happen in the future. For including the Agency for Health Care Policy and Research (now example, we might imagine that we are looking at the world before known as the Agency for Healthcare Research and Quality), the we are born or before we have contracted any illnesses. From this National Institutes of Health, the Healthcare Financing Adminisperspective, we would want all possible treatments available betration, the Centers for Disease Control, and several others. The cause they might be needed to treat a condition that will eventually charge of the panel was to develop recommendations for consistent affect us (Daniels, Crawford, & Sabin, 1997; .
practice of cost-effectiveness analysis in preventive medicine, It is argued that this position is most fair because people making medical therapy, rehabilitation, and public health. Ultimately, the the decisions do not stand to gain or lose by favoring a condition goal was to create common standards. The work of the panel was that they already have. Decisions are made based on the serious-" 485 nessof the problem and the ability of the intervention to remedy it. life by curing or preventing disease. We want to be well to function The perspectives of specific individuals with a defined medical and enjoy life (Kaplan, 1994) . Outcome measures have been problem and the special interests are de-emphasized. In reality, develope d to quantify these behavioral .indicators of wellness, administrators may base their decision On what is best for their These measures are-now commonly used in clinical research company's profit margin, but the main point is that scientific (Spilker, 1996) .' studies should remain objective and provide decision makers with.
Outcome measurement.models are .refinements of generic suras much information as possible, rival analysis. In traditional survival analysis, the living are statistically coded as 1.0, whereas the dead are statistically coded as 0. Mortality can result from any disease, and survival analysis Comparators . allows comparisons between different diseases. For example, the It makes little sense to say that a program is cost-effective, life expectancies for those who will die of heart disease can be Cost-effective in comparison with what? Virtually all decisions compared with the life expectancies of those who will die as a involve evaluating in comparison with some alternative.A "cornresult of alcohol abuse. The advantage of these genetic measures parator" is the alternative to which a new trea_-nent is compared, over "disease-specific measures of heart or liver function .is that For example, behavioral management of back pain could be corngeneral comparisons of life expectancy can be considered.. The pared with no treatment at all, surgery, or medical management, disadvantage isthat all individuals who are alive are considered to
The choice of. the comparator is of critical importance in the be equal. A person confined to home because of severe depression analysis. Evaluations of innovative new therapies should compare is scored the same as someone active and participating in many the new approach with care that was usual before the new interareas. Utility assessment allows the quantification of levels of vention was available. The Panel on Cost-Effectiveness in Health wellness on the continuum anchored by death and wellness (Lenert and Medicine (Gold, 1996) Kaplan, 1997) . QALYs integrate mortality and mortreatment or seek an alternative remed);. Therefore, 'a no-treatment bidity to express health status in terms of equivalents of well-years control group is usually not the most realistic comparator. The of life. If a woman dies of breast cancer at age 50 and one would standards for cost-effectiveness analysis suggest that costsand have expected her to live to age 75, the disease was associated effects be evaluated for both the treatment and the comparator and with 25 lost life years. If 100 women died at age 50 (having life the difference in cost-effectiveness be reported.
'expectancies of 75 years), 2,500 (100 ×.25 years) life years would be lost.
Measure of Effectiveness
Death is not the only outcome of concern in cancer. Many adults continue .to suffer from the disease, which leaves them somewhat • The purpose of health care is to improve health, yet as explaine d disabled over long periods of time. Although they are still alive, above, many studies never measure he_ilth outcomes. Instead, they the quality of their lives has diminished. QALYs take into confocus on dollars saved by the decreased usage of health services, sideration the quality of life consequences of these illnesses. For Next, researchers might "ask: "What health outcomes should we example, a disease that reduces quality of life by one half will take measure, and how do we measure them?" away .5 QALYs' over the course of 1 year. If it affects two people, Behavioral outcomes have become common in the evaluation of it will take away 1 QALY (2 X .5) over a 1-year period. A biomedical interventions. More than 35 years ago, Sulliv_ (1966) pharmaceutical treatment that improves quality of life by .2 for published a keygoverntuent document that argued that behavioral each of five individuals will resuk in the equivalentof 1 QALY if indicators such as absenteeism, disability days, and institutional the benefit is maintained over a 1-year period. The basic assumpconfinement were .the key indicators of disease and disability, lion is that life years, can be adjusted for quality of life by Health outcome measures began to emphasize the ability to permultiplying the time in each health state. by its quality of life form actiyities of daily living and the restriction in usual activities, preference weight to estimate QALYs. QALYs can be added
The key indicators of illness are largely behavioral (Kaplan, 1990 ). together and estimated over multiple patients and multiple years. Diseases and disabilities are important for two reasons. First;
This system has the advantage of considering both benefits and illness may cause life expectancy to be shorter, and second, illness side effects of treatment programs in terms of the common QALY may make quality of life less. desirable . Diseases, units. disabilities, environmental exposureS, or risky behaviors are imAnother strength of using QALYs is that they incorporate portant because they inay shorten life expectancy or lead to reducchanges in symptoms and functioning that traditionally have been tions in quality of life. Treatments or preventive:interventions are. components of behavioral measurements. The behavioral medicine valuable because they might make life longer or improve quality of field has been a leader in demonstrating the connection between 486 KAPLAN AND GROESSL mind and body. However, many behavioral intervention s.tudies different interventions. A second advantage of QALYs is that they have not measured health outcomes or the effect of treatment on are scaled in relation.to perceived benefit. For example, the meanpsychological well-being. By recast/ring a wide spectrum of symping of the change from .6 to a score of .7, is defined by judgments toms and concentrating on function, researchers' proper assessof peoplein the community. A change of .1 means that peers see ment of QALYs includes global well-being, including psychologthe change as about one tenth of the distance between death and jcal aspects, perfect health. The numbers have meaning independent of referAlthough sometimes initially daunting to researchers, using ence to normative data bases. A third advantage of QALYs is that cost-utility analysis and measuring QALYs offers an excellent they have social significance. Cost/QALY allows the estimation of opportunity for promoting behavioral medicine and psychological the relative benefit of investing in alternative, programs. Ultiinterventions in general. A recent example considered two pathmately, the goal of cost-utility analysis is to find the best use of ways to enhance the population health status . One community resources. In other words, the goal is to use the pathway requires the early diagnosis and treatment of diseases available resources to produce the most health for society. such as cancer. The second pathway promotes health through changes in .lifestyle. The unusual aspect of the second pathway is Accounting for Costs that it completely disregards the requirement that a condition be diagnosed before intervention is recommended. Using cost-utility
Costs are an important component of cost-effectiveness analyanalysis, it was suggested that behavioral programs that promote sis. From the societal perspective, the cost analyst considers all • resources requiredfor the intervention and for thecomparator. An physical activity or reduce tobacco use result in significantly more evaluator of a preventive intervention, for example, must consider QALYs per dollar investment than do many widely accepted prevention programs that require diagnosis through the early deall costs required to deliver the intervention or the comparison program. These include all costs for all people exposed to the tection of breast or prostate cancer. It was argued that the objecprogram whether or not they eventually developed a health probtires of improved population health might be better served by lem. From an administrative perspective, direct cost estimates devoting more resources to behavioral prevention programs_ include all costs of treatment and any costs associated with caring In summary, QALYs combine measures of morbidity and mortality and do not require medical diagnoses. The measures include for side effects of treatment. Direct costs may be the only ones time or prognosis and incorporate preferences for health outcomes, recognized by the administrative perspective. However, from the A consensus conference with the Department of Health and Huperspective of the'patient or from a societal perspective, several man Services recommended the use of QALYs to evaluate health indirect costs must be realized. Indirect costs include patient time programs . A recent Institute of Medicine report required for therapy-, income lost because a family member offers on the measurement of population health came to similar concluhome care, and morbidity and mortality cost_ _associated with reduced productivity due to disability or premature death. A thorsions (Field & Gold, 1998) .
ough analysis must also include the intangible costs associated with pain and suffering. Although some researchers tiave-argued
Clinical Significance over what should be considered as direct or indirect costs, guidelines have been developed to ensure thoroughness and consistency Systematic randomized clinical trials can be used to establish across studies . whether the outcomes for an experimental treatment are signifiIn cost-benefit analysis, the cost savings in reduced health care cantly distinguishable from those attributable to control or placebo • are subtracted from the cost of an intervention. For examp!e, a interventions. However, clinicians are not always convinced that behavioral intervention to manage anxiety may reduce the number statistically significant results are clinically meaningful. Clinical significance describes the meaningfulness or convincinguess that a of visits to health care providers. If the resources saved by reduced visits exceed the costs of the programs, a cost-offset has been i treatment produces benefits from the perspective of the clinician or achieved. However, some authors question the common belief that :. the patient (Kendall & 'Sheldrick, 2000) . Kendall and 'associates behavioral intervention programs actually save money (e.g., Rus- (Kendall & Flannery-Schroeder, 1998; Kendall, Marrs-Garcia, Nath, & Sheldrick, 1999) have argued that clinically meaningful sell, 1986). Often, after a more thorough analysis, the cost-offsets have been difficult to document. For example, some have argued change .brings a person to within normal limits in relation to a that treatment often results in productivity gains (Pelletier_ 1993). normative population. Kazdifi (1999) , noting ambiguities in sevThese gains in productivity may occur because healthy people who eral measures of clinical significance, suggested that outcomes should be evaluated in relation to clinical goals. Cutoff scores for live longer are able to contribute more to the economy through work and to pay more taxes. These approaches have been seriously meaningful clinical change should be set and treatments should be criticized because they value only the portion of life used for paid considered in relation to their impact on Society. Social validity work (Lehman et al., 1999 ). The models exclude or devalue evaluates the impact of treatments on society (Foster & Mash, activity such as child care, schoolwork, or volunteer efforts. Fur-1999) .
ther, these methods place greater weight on wealthy individuals
QALYs provide'an alternative approach to these problems. One and may favor programs thatcare for the rich (Lave, Frank, of the advanhages of QALYs is that they describe outcomes in a unit that has intuitive .meaning. All treatments are considered in Schulberg, & Kamtet, 1998) .
relation to the number of years of life (adjusted for quality) that Discounting Costs and Outcomes they produce. As all treatments are measured in a Common unit, the benefits can be directly compared, and there is a substantial It is commonly acknowledged in economic theory that future normative database that shows the amount of gain achieved with gains (or losses), should be discounted because most people prefer positive events or rewards sooner and negative events Or punishsearch identified 24,562 references on costs or cost-effectiveness ments later in time (Berwick, Cretin, & Keeler, 1981 Medicine, 2000 Medicine, , 2001 . Although thereview earlier in life in the same manner as money and should therefore be example above pertained to' only a limited time frame and to only discounted in a similar manner (Weinstein & Stason, 1977) . Howone database, it is clear that cost-effectiveness remains under-used ever, there is still considerable debate about whether this is correct in behavioral medicine. (Parsonage & Neuburger, 1992) . The.Panel on Cost-Effectiveness Many researchers have proclaimed that there is plenty of eviin Health and Medicine reviewed the .issue and found it to be very denee that behavioral interventions are cost-effective (e.g., Pellecomplex . They concluded that, until a different tier, 1993). However, behavioral medicine interventions are rarely consensus is reached, for the purposes of standardization, health cited in reviews of the health care COst:effectiveness literature. In outcomes should be discounted at the same rate as monetary costs, part, this happens because some behavioral interventions are not They recommended a discount rate of 3.0% per year.
considered to be medical. The more obvious reason, however, is that many analyses of cost,effectiveness do not meet many of the Time Horizon and Modeling current standards for cost-effectiveness . Among the The time horizon concept simply refers to how long after the nine articles identified irt the Medline search, none was an original intervention Costs and outcomes are evaluated. Preventive interstudy. Eight of the nine articles discussed basic issues without ventions may change outcomes over a lifetime or longer, if subpresentation of data. The ninth article is an important piece by sequent generations are impacted bY the intervention. Obviously, Friedman et al. (Friedman, Sobel, Myers, Caudill, & Benson, the longer the follow-up period the better, as there is always the 1995) that systematically reviews evidence of c0st-offset in bepotential for unintended side effects or benefits in the distant havioral medicine, Because the Friedman ariicle is so widely cited, future. However, it is not possible to accurately measure health we decided to look carefully at the data reviewed for their analysis outcome data or costs indefinitely, and the supporting evidence for related claims of cost-offset,
An increasingly popular technique for extending the time horiIn reviewing the literature cited in the Friedman et al. (1995) zon of a Cost-effectiveness analysis is the modeling of future
article, we found several articles arguing that behavioral intervenoutcomes. Modeling uses estimates of the probability of each tions are valuable because they reduce overall health care costs. possible health .outcome to calculate future costs and health conHowever, improved overall health, not cost reduction, is the most sequences of the intervention by computer. Probability estimates important criterion for justifying any health service. For example,. for some health problems have been fairly well established through health costs can be reduced by making access to care difficult. As epidemiological research. However, there are also concerns about the great majority of health care utilization is for self-limiting how much of the future probability should be estimated from past problems, simply denying access reduces .costs, with arguably little •data. Sensitivity analysis, which will bebriefly discussed in the affect on health outcome. In several of the studies cited, a costnext section, is one way to address some of this uncertainty, but it offset occurs because a less expensive service is substituted. In one is not a complete remedy for these concerns, study (Vickery et ai., 1983) , patients were randomly assigned to receive a self-care book, a telephone information service, individSensitivity Analysis ual: counseling by a trained nurse, or the usual Care. The self-care
Sensitivity analysis is a statistical technique .that is not. specific guide offered instructions on more than. 100 common symptoms. to cost-effectiveness analysis but is usually included in. higher Those who received the book and had access to the telephone ,quality cost-effectiveness evaluations. Almost every study on costservices used health care services for minor self-limiting probeffectiveness uses estimates of costs or rates of outcome. For lems 35.0% less often. Each $1.00' spent on the program resulted example, actual health care costs are often hard to identify, bein $2.50 saved in medical care costs.
cause these costs vary widely and often contain sensitive or conAs attractive as these findings are, they do not show that patients fidential information. Health care utilization rates .are easier to experience health benefits as a function of participation in these obtain,_ but they require an estimate of the cost per type of utiliprograms. The intervention has a benefit, and cost-offset occurs zation." Likewise, effect sizes from multiple studies of a very because: patients use services less often. An intervention's costsimilar intervention may vary widely, so an estimate of ttie average effectiveness ratio .might be improved because cost has changed, effect size is used. Sensitivity analysis examines how the results of and it is presumed that the patients are no worse off. Yet, we do not •the cost-effectiveness analysis would change if these estimated know that because health status was not measured. Might patients values were allowed to vary between a realistic upper and lower who were. using this system less have had some aspects of their bound. In other words, researchers examine and report how senillness overlooked? We simply do not know. In this section, we provide a more detailed review of some of the review suggested that there are small but consistent effects of studies that reported that behavioral medicine services are costpsychological and educational interventions for outcome measures effective or produced a cost-offset. We restricted the review to recent studies because cost-utility nlethodologies for estimating such as postoperative pain, psycholog!cal distress, and recovery from surgery (Devine, 1992) . However, the review did not forcost/QALY were not well known and were rarely "used before mally consider fluecost-effectiveness of these interventions. Klaus, " 1988. As mentioned earlier, our focus is on the application of Kennell, Berkowitz, and Klaus (1992) reviewed 5 studies on contemporary methodologies rather than on the provision of a maternal assistance and support during childbirth. Again, none of comprehensive review of the literature. the studies considered economic impact.
To evaluate studies, we considered the following criteria. 1. What perspective was used to evaluate the study (i.e, conTwo reviews specifically evaluated the economic impact of sumer, clinician, administrative, societal)? behavioral or psychological interventions (Gabbard, Lazar, Horn-2. Was a systematic experimental design used tO evaluate the berger, & Spiegel, 1997; Pelletier, 1993) . One review (Gabbard et treatment? Was it a randomized clinical trial, an observational al.,. 1997) considered 686 articles published between 1984 and study, or some other design?
1994. Articles were excluded from further consideration if they did 3. What was the comparator.for the analysis? not have a cofitrol group, if they focused on a medical disorder 4. Were all costs of treatment accounted for?
instead of a psychiatric illness, or if the outcomes did not:include 5. Did the analysis consider costs of treatment for patients who cost data. Among the 686 articles, 41 articles describing 35 studies did not get ffie disease? were considered further and 18 of the studies were judged of 6. What was the unit of ontcome? Was it cost? Health? QALYs? sufficient quality to be included for final consideration. Studies
Was mental health considered?
were classified as to whether patients were assigned to the treat-7. Were future outcomes discountedto current value? ment or control group using randomization. Most of the clinical Table 2 summarizes the review of some commonly cited trials using randomization and aU of those without randomization studies on cost-effectiveness in behavioral medicine. The studsuggested that psychotherapy reduces total health care costs. Most ies involved a variety of different patient populations including cost savings occur because of reduced in-patient treatment and nondiagnosed adults, adults with high blood pressure, adults increased capacity to work (Gabbard et al., 1997) instead of with somatization disorders, adults with acute myocardial inbecause overall health status was improved (Gabbard et al., 1997) .
farctions, women giving childbirth, individuals with hip frac- Pelletier (1993) reviewed studies on the cost-effectiveness of tures, individuals with chronic arthritis, individuals with HIV, comprehensive health promotion programs at the work site. The and individuals with other serious chronic problems. When article was an update of an article he published in 1991. Pelletier considered in methodologlcal context, few of the studies used noted that he received 6,500 requests for reprints for his original measures of health outcome that allow cost-utility comparisons. article and suggested that anyone challenging the evidence for the In fact, studies published before 1995 rarely considered the cost-effectiveness of behavioral interventions at the work site is ;. effects of interventions on measures of overall health. This "simply ignorant of more than 13 years of increasingly sophistitrend was reversed with more recent studies, which have becated research with documentation of both health and cost outcome more likely to consider cost-effectiveness or cost-utility.
comes" (Pelletier, I993, p. 51 Gold and colleagues Kashner, 1995) . Nearly all of the studies perfo/med calculations . It is true that the ourrent standard of methodfrom the administrative perspective, but a few did acknowledge ology has changed considerably since 1991, but many of the the value of the societal perspective. • " For the great majority of the studies, the time horizon was studies used intermediate outcome variables such as blood Presrelatively short, almost always fewer than 5 years. The behavioral sure and cholesterol levels without considering quality of life interventions in the studies varied widely. In some studies, behavoutcomes or the impact of the intervention on other areas of health.
ioral intervention was simply providingeducational information, Indeed, since the publication of the Pelletier (1991) review about . whereas in others it was intensive and long-term intervention. In the benefits of community intervention programs, several studies reviewing these studies, we discovered that several articles, cornhave challenged the efficacy of major community intervention moniy cited as supporting the cost-effectiveness of interventions, efforts (Luepker et al., 1996) . never actuaily considered or reported measuring the cost of the Our conclusion is not that behavioral medicine, preventive, o_ intervention (Fahrion, Norris, Green, Green, & Snarr, 1986) .. An community interventions are not cost-effective or should not be important study by Ornish et al. (1990) iS commonly cited as implemented. Instead, the purpose was to critically examine the supporting the cost-effectiveness of intensive behavioral intervenmethodologies used to arrive at the results that have been dissemtions (e.g., Friedman et al., 1995) . However, cost-effectiveness inated and to suggest that there is lots of room for improvement, data were not presented in the Ornish article cited by Friedman et Sound and credible improvements in cost-effectiveness methodolal. (1995) . Kennell, Klaus, McGrath, Robertson, and I-Iinkley ogles should not be ignored because they have been developed by (199t) demonstrated the reduced use of services and cesarean economists or biostatisticians, sections for women who received emotional support during labor.
Although the article is commonly cited as demonstrating the aiions . These guidelines addressed many limitations of cost-effectiveness of intervention (Friedman et al., 1995) , there is earlier analyses and provide guidance for the design and analysis of no formal cost analysis. Instead, there is a speculative paragraph in studies. Therefore, it is important for outcome studies in behavioral the discussion arguing that costs would be reduced if the intervenmedicine to make use of these standards.
tion was used. One commonly cited article (Pallak, 1995) sugOur review of the current literature suggests several conclugested,that managed mental health care reduces medical.care costs sions. First, the literature consistently shows that behavioral and and produces a cost-offset. However, the article did not include psychological interventions do reduce utilization of health care formal accounting of program costs. Similarly, a study by Robinservices. These findings are consistent across a wide range of son, Schwartz, Magwene, Krengel, and Tamburello (1989) is cited studies. Further, the literature suggests that there is a c0st-offset as showing cost-offset, but it also presented no formal cost acassociated with these services.
• counting. The study suggested that there was a cumulative effect of However, despite the appearance of benefit, few studies meet the an educational intervention. However, inspection of the data in the criteria for high-quality cost-effectiveness evaluations. According to article suggests that most of the benefit occurred within the f_st 30 current standards, studies should consider a societal perspective rather days.
than simply the perspective of the administrative unit paying the bills.
Many of the studies are difficult to evaluate in relation to current A second concern is that full-cost accounting has rarely been used. medical care. Length of stay for most surgeries and medical Behavioral services, like other services, cost money. The cost acillnesses has decreased substantially in the past few years. Strain et counting must include not only the fees of service provided but also al. (1991) were able to demonstrate that psychiatric consultation the overhead costs associated withproviding the care and possibly the reduces hospitalization for hip fracture by about 2 days. However, indirect _costs. A third concern is _at few studies have adequately after the consultation, the length of stay was 18.5 days at one measured health outcomes. It is not sufficient to say that a service hospital they studied and 13.8 days at another hospital. The probreduces costs. An inexpensive service that harms patients or places lem is that the length of stay for hip fracture has decreased quite them at risk cannot be advocated. Studies need to show that behavsignificantly in the past few years because of a variety of factors, ioral services either produce equivalent benefit at a lower cost or Currently, the total length of stay is estimated to be about 3 to 4
. produce greater benefit atan equal cost to competing services to be days in California. Managed care has reduced length of stay so considered cost-effective. dramatically that it is unclear how much remains to be improved
The guidelines for cost-effectiveness in health and medicine through psychiatric consultation, offer several suggestions for the design of studies (Gold et al., There are two studies in Table 2 in which the researchers 1996). Some of these issues are summarized in Table 3 . Authors adhered to many of the standards proposed by the Panel on should report the perspective of their study, and clearly describe Cost-Effectiveness in Health and Medicine (Pinkerton et al., 1997;  comparators. They should also discuss uncertainty and include Salkeld et al., 1997) . Although both of these studies involved the sensitivity analysis where appropriate.
computer modeling of future outcomes, the authors took a societal The best opportunities to provide cost-effectiveness data are to perspective and calculated the cost-effectiveness of both the interinclude measurements of cost and health-related quality of life in vention group and the comparator. They measured (or estimated) randomized clinical trials. Ideally, the health-related quality of life health outcomes in QALYs (which includes mental health conmeasure would be one that can be used to estimate QALys. There ceres) and did a good job of attempting to account for all possible are a number of such measures currently available. They include , costs. In addition, both studies conducted' sensitivity analyses, the Health Utilities Index (Feeny, Furlong, Boyle, & Torrance, In general ; the studies have improved steadily over time, audit 1995; see also http://www.flls.mcmaster.ca/hug), the Quality of should be noted that many of these studies were designed long Well-Being Scale (Kaplan, Ganiats, Sieber, & Anderson, 1998 ; see before the current methodology and guidelines were established, also http://orpheus.'ucsd.edu/famed/hoap/MEASURE.html), and There are also practical limitations with respect to strictly followthe Euro Qol Five Dimension Scale (Gudex, Dolan, Kind, & _ ing the c0st-effectiveness guidelines in every study. Therefore, Williams, 1996; see also http://www.eur0qol.org) ! these studies should be viewed as valuable building blocks in the Cost information should include all direct and indirect costs of the intervention and the alternative with which the treatment is _-transition toward better use of existing methodology in costj: effectiveness analysis, being compared. Costs should also include secondary costs, such as loss of income to family members or support persons who take time off from paid work to care for a patient. Longer time horiConclusion .... zons, especially for preventive interventions are also an important goal. Finally, sensitivity analyses are needed to evaluate the variIt is commonly argued that behavioral medicine services are costability of estimated values. These recommendations should be i effective; yet the evidence appears to be based mostly on incomplete, considered at the earliest phase of research design; they become '_inconsistently applied, or outdated methodologies. Our review idenmuch more difficult to.achieve when.attempted.retrospectively.
;. _1_ few systematic evaluations of behavioral medicine services, This articleis not meant to be a comprehensive review of all studies :i which is in contrast to other areas of health care where costof cost-effectiveness in behavioral medicine but should serve as an i effectiveness evaluations are becoming refined and commonplace., assessment of the progress the field has made in this area and as an ! _Among the few published reports, there is considerable confusion indication of the remaining areas in need of improvement. Behavioral :ii._b,tweeaterms such as cost-effectiveness, cost-utility,, cost_benefit, medicine has long claimed to be cost-effective, but•it has not produced and cost-offset. A panel on cost-effectiveness representing several enough evidence that is well-accepted by colleagues. Using the curi -'E.S.federal agencies has set guidelines for cost-effectiveness evalurent standardized methods is a challenging task, but users will offer benefits and compete favorably with other health Services. However, There are many.aspects of cost-effectiveness and cost-utility anal- Results should be reported in relation to a well-defined reference case. The reference case describes the treatment and the characteristics of the subject population to which it was applied. Components of report .Total cost, total effectiveness (in QALYs), incremental costs, incremental effectiveness, incremental cost-effectiveness, and discount rate should be included.
Discounting
Costs and effects should be discounted to their present value. (Typically, this is 3%, but 9ther alternatives are possible.) Sensitivity "
Uncertainty should be formally evaluated through sensitivity analysis.
Note. QALYs = quality-adjusted life years.
the analyses offer additional information to decision makers. It is, predictors of long-term outcome after acute myocardial infarction m however, one of the most useful, accurate, and objective ways to men. American Journal of Cardiology, 67, 121-127. evaluate health interventions and to maxirrtize the overall health of a Friedman, R., Sobel, D., Myers, P., Caudill, M., & Benson, H. (1995) .
population. When used appropriately, cost-utility analysis might offer Behavioral medicine, clinical health psychology, and cost offset. Health a highly ethical utilitarian approach to achieve the best health status Psychology, 14, 509-518.
for a defined population . Fries,J. F., Bloch, D. A., Harrington, H., Richardson, N., & Beck, R. (1993) . 2-year }esults of a randomized controlled trial of a health promotion program in a retiree population--the Bank of America study.
